Archived News Releases

Pacira BioSciences to Participate in Fireside Chat at the 2023 Jefferies Healthcare Conference

05/31/23

Pacira BioSciences to Participate in Fireside Chat at the 2023 RBC Capital Markets Global Healthcare Conference

05/09/23

Pacira BioSciences Reports First Quarter 2023 Financial Results

05/03/23

Pacira to Report First Quarter 2023 Financial Results on Wednesday May 3, 2023

04/26/23

Pacira BioSciences Partners with The Invited Celebrity Classic – a PGA TOUR Champions Event – to Make iovera° The Official Non-Opioid Pain Management Partner

04/20/23

Pacira BioSciences, Inc. Appoints Christopher Young as Chief Manufacturing Officer

04/19/23

Pacira BioSciences to Participate in Fireside Chat at the 22nd Annual Needham Virtual Healthcare Conference

04/12/23

Pacira BioSciences Announces Repayment and Termination of Term Loan B Facility Using Proceeds from New $150 Million 5-Year Term Loan A Facility and Existing Cash Resources

04/03/23

Pacira Announces FDA Acceptance of sNDA for Exparel Nerve Blocks to Produce Regional Analgesia in Lower Extremity Procedures

03/29/23

Third Circuit Court Upholds Decision to Dismiss Pacira BioSciences, Inc. Lawsuit

03/27/23

Pacira BioSciences Announces Yvonne Greenstreet to Retire from Board of Directors

03/22/23

Pacira BioSciences to Participate in Fireside Chat at the 2023 Barclays Global Healthcare Conference

03/08/23

Pacira BioSciences Reports Full-Year and Fourth Quarter 2022 Financial Results

02/28/23

LPGA, Pacira BioSciences Partner to Raise Awareness of Non-Opioid Pain Management Solutions

02/23/23

Pacira to Report 2022 Financial Results on Tuesday February 28, 2023

02/21/23

Pacira BioSciences Reports Preliminary Unaudited Total Revenue for 2022 of $666.8 Million

01/05/23

Pacira BioSciences to Present at the 41st Annual J.P. Morgan Healthcare Conference

01/04/23